Barclays lowered the firm’s price target on Fresenius Medical (FMS) to EUR 40.50 from EUR 42.50 and keeps an Equal Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical Care Announces AGM and New Capital Structure
- Fresenius Medical Care Completes Bond Tender Offer with Increased Acceptance
- Fresenius Medical Care AG Announces Strategic Debt Management Initiative
- Fresenius Medical Care Secures €1.1 Billion Through Bond Issuance
- Fresenius Medical Care’s Earnings Call Highlights Growth and Challenges